Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1/2
The trial team wanted to find the best dose of olaparib to treat leukaemia and lymphoma and if it might help people live longer. It was open to people with:
Recruitment start: 13 July 2011
Recruitment end: 23 January 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Guy Pratt
AstraZeneca
Bloodwise
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Birmingham
Last reviewed: 25 January 2019
CRUK internal database number: 7447
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
